Saturday, November 21, 2009 
|
|
|
| subscribe | manage account |
It is not the intent of this list to endorse its participants, nor to imply that the company's size or numerical rank indicates its quality or service. We reserve the right to exclude a listing due to insufficient information.
Ranked by: Market Capitalization
| Company Name | Market Capitalization | Ticker Symbol | Fields of Research |
|---|---|---|---|
| Life Technologies Corp. (formerly Invitrogen) | $8,273,849,000 | LIFE | Gene cloning and expression, electropharesis, protein purification, characterization and production, enzyme chemistry, molecular labation and detection. |
| Illumina Inc. | $5,064,851,000 | ILMN | Large-scale analysis of genetic variation, function. |
| ResMed Inc. | $3,760,719,000 | RMD | Sleep-disordered breathing |
| Gen-Probe Inc. | $2,140,342,000 | GPRO | Nucleic acid diagnostics for human disease |
| Amylin Pharmaceuticals Inc. | $1,732,936,000 | AMLN | Developing innovative medicines to beat metabolic diseases |
| NuVasive Inc. | $1,486,431,000 | NUVA | Design, development and marketing of products |
| Isis Pharmaceuticals Inc. | $1,301,900,000 | ISIS | RNA-based drug discovery and development to treat metabolic, cardiovascular, inflammatory and viral diseases, cancer, biosensor to identify infectious organisms, small molecule drugs that bind to RNA. |
| Sequenom Inc. | $1,002,469,000 | SQNM | Genomics, drug target discovery |
| Biosite Inc. | $801,838,400 (as of 1/07) | BSTE | Development of rapid medical diagnostic tests |
| IMCOR Pharmaceuticals Co. | $765,870,100 | ICRP | n/a |
| Halozyme Therapeutics | $610,117,700 | HALO | n/a |
| Genoptix, Inc. | $608,903,700 | GXDX | Hematology and oncology |
| Diversa Corp. | $508,959,200 (as of 1/07) | DVSA | Pharmaceutical, agriculture, chemical and industrial. |
| Quidel Corp. | $450,989,400 | QDEL | Reproduction, infectious diseases, general health screening, bone health, autoimmune disorders. |
| Arena Pharmaceuticals Inc. | $419,589,400 | ARNA | G protein-coupled receptors. |
| Dexcom Inc. | $335,583,200 | DXCM | Pioneering technologies for the continuous monitoring of glucose in people witj diabetes |
| Avanir Pharmaceuticals | $269,412,000 (as of 06) | AVNR | Central nervous system disorders, inflammatory diseases, monoclonel antibody generation. |
| Cypress Bioscience Inc. | $266,870,600 | CYPB | Providing products for the treatment of patients with functional somatic syndromes and other central nervous system disorders |
| Ligand Pharmaceuticals Inc. | $216,913,600 | LGND | Cancer, pain, dermatology, men's and women's health, osteoporesis, metabolic disorders, cardiovascular and inflammatory diseases. |
| Santarus Inc. | $186,324,400 | SNTS | Acquiring, developing and commerciating products for the prevention and treatment of gastrointestincal (GI) diseases |
| Anadys Pharmaceuticals Inc. | $80,589,370 | ANDS | Developing medicines in the areas of hepaitis C, oncology |
| Vical Inc. | $170,949,100 | VICL | Gene-based vaccines, pharmaceuticals for human therapy. |
| Stratagene Corp. | $170,514,000 (as of 1/2007) | STGN | Molecular biology, genomics, proteamics, drug discovery and toxicology |
| Senomyx Inc. | $122,745,100 | SNMX | Products relevant to taste and olfaction |
| Inovio Biomedical Corp. | $122,369,200 | INO | Oncology, gene delivery and other applications |
| SeraCare Life Sciences Inc. | $121,053,400 (as of 2006) | SRLS | n/a |
| SGX Pharmaceuticals | $108,919,700 | SGXP | Cancer therapeutics |
| Neurocrine Biosciences Inc. | $99,675,250 | NBIX | Insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, autoimmunity |
| MediciNova Inc. | $72,288,020 | MNOV | Engages in the acquistion and development of small molecular therapeutics |
| Discovery Partners International Inc. | 69,657,450 (as of 06) | DPII | n/a |
| Pure Bioscience | $61,427,060 | PURE.OB | Pharmaceutical, water purification and dispensing, and home drinking water. |
| Acadia Pharmaceuticals Inc. | $56,346,890 | ACAD | Central nervous system disorders |
| Natural Alternatives International Inc. | $54,712,460 | NAII | Provides private label contract manufacturing services to companies that market and distribute vitamins, minerals and other nutritional supplements |
| Somaxon Pharmaceuticals Inc. | $50,967,660 | SOMX | In-licensing, developing proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology |
| CancerVax Corp. | $40,147,000 (as of 06) | CNVX | n/a |
| CryoCor Inc. | $39,081,750 | CRYO | n/a |
| Aethlon Medical Inc. | $37,002,830 | AEMD.OB | Hemopurifier that removes harmful substances from the blood |
| Metabasis Therapeutics Inc. | $31,726,000 | MBRX | Engages in the discovery, development, commercialization of novel drugs for targeting the liver and liver pathways |
| Hollis-Eden Pharmaceuticals Inc. | $17,002,940 | HEPH | Engages in he development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals for human health |
| Adventrx Pharmaceuticals | $15,313,080 | ANX | n/a |
| CardioDynamics International Corp. | $6,279,477 | CDIC | n/a |
| La Jolla Pharmaceutical Co. | $5,257,812 | LJPC | Antibody-mediated diseases |
| Nanogen Inc. | $3,291,864 | NGEN | Molecular diagnostics, point of care diagnostics, genomics, enabling technology. |
| JMAR Technologies Inc. | $2,644,629 | Nasdaq: JMAR.OB | n/a |
| Protein Polymer Technologies Inc. | $2,385,908 | PPTI.OB | Surgical adhesives, soft-tissue augmentation, drug delivery and adhesion barriers. |
| Alliance Pharmaceutical Corp. | $2,356,081 | ALLP.OB | Oxygen therapeutics, pulmonary, immunology, cardiovascular. |
| Lancer Orthodontics Inc. | $969,087 | LANZ.OB | Orthodontics. |
| Vyrex Corp. | $356,701 | VYXC | n/a |
| iVow Inc. | $277,989 | IVOW | n/a |
| Naturewell Inc. | $244,866 | NAWL.OB | The distribution and sale of its migraine medication, MigraSpray®, a homeopathic, over-the-counter drug used for the treatment and prevention of migraine headaches without side effects. |
| Cordex Pharma | $224,293 | CDXP | n/a |
| MicroIslet Inc. | $170,563 | MIIS.OB | Diabetes |
| Molecular Imaging Corp. | $56,267 | MLRI | n/a |
| Miracor Diagnostics Inc. | $23,027 | MRDG | n/a |
| BD Biosciences - Pharmingen | n/a | BDX | Manufacturing reagents for biomedical research. |
| Beckman Coulter Inc. | n/a | BEC | Instrument systems and complementary products that simplify and automate laboratory processes and biomedical testing. |
| Biogen Idec | n/a | BIIB | Idec is developing targeted immunotherapies for the treatment of cancer and autoimmune diseases. |
| DJO Inc. | n/a | DJO | n/a |
| Elan Corp. | n/a | ELN | Neurology, autoimmune diseases, severe pain |
| Exelixis Inc. | n/a | EXEL | n/a |
| Genzyme General Diagnostics | n/a | GENZ | n/a |
| IDM Pharma Inc. | n/a | IDMI | n/a |
| Maxim Pharmaceuticals Inc. | n/a | MAXM | Therapies for cancer and infectious diseases. |
| Migenix Inc. | n/a | MGIFF.PK | n/a |
| Parexel International Corp. | n/a | PRXL | n/a |
| Synbiotics Corp. | n/a | SYNB.PK | Develops, manufactures and markets diagnostic products and biological products for animals. |
| Tanox Inc. | n/a | TNX | n/a |
| Ultimate Labs | wnd | n/a | n/a |